Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suxin Yuan"'
Autor:
Maowen Luo, Xingzhao Luan, Chaoge Yang, Xiaofan Chen, Suxin Yuan, Youlin Cao, Jing Zhang, Jiaying Xie, Qinglian Luo, Ligang Chen, Shenjie Li, Wei Xiang, Jie Zhou
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Gliomas are primary tumors that originate in the central nervous system. The conventional treatment options for gliomas typically encompass surgical resection and temozolomide (TMZ) chemotherapy. However, despite aggressive interventions, the median
Externí odkaz:
https://doaj.org/article/04ce4c93f56043ac8eabac8df60bfd99
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Diabetic cardiomyopathy seriously affects quality of life and even threatens life safety of patients. The pathogenesis of diabetic cardiomyopathy is complex and multifactorial, and it is widely accepted that its mechanisms include oxidative stress, i
Externí odkaz:
https://doaj.org/article/579029c9df984db4bd34234f18d2d0fc
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Pyroptosis is a highly specific type of inflammatory programmed cell death that is mediated by Gasdermine (GSDM). It is characterized by inflammasome activation, caspase activation, and cell membrane pore formation. Diabetic cardiomyopathy (DCM) is o
Externí odkaz:
https://doaj.org/article/4294d47af5b243d7b636faee0a483014
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Diabetes mellitus (DM) eventually leads to chronic vascular complications, resulting in cardiovascular diseases. DM-associated endothelial dysfunction (ED) plays an important role in the development of chronic vascular complications. Low endothelial
Externí odkaz:
https://doaj.org/article/011a8aadb0b34bafb41269ce6db0096b
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Diabetes mellitus (DM) eventually leads to chronic vascular complications, resulting in cardiovascular diseases. DM-associated endothelial dysfunction (ED) plays an important role in the development of chronic vascular complications. Low endothelial